Status:
UNKNOWN
Project RAD: A Brief Intervention for Young Adult Alcohol or Marijuana Users
Lead Sponsor:
University of Houston
Conditions:
Alcohol; Use, Problem
Marijuana Usage
Eligibility:
All Genders
18-25 years
Phase:
NA
Brief Summary
This is a pilot study of the feasibility, acceptability, and effectiveness of a brief, one-session intervention for a diverse sample of 44 young adults who report alcohol binge drinking or marijuana u...
Detailed Description
This study is a preliminary examination of the feasibility, acceptability, and effectiveness of a brief, one-session intervention for a diverse sample of young adults who report alcohol binge drinking...
Eligibility Criteria
Inclusion
- Between the ages of 18 and 25.
- Able to speak and read the English language.
- Agree to participate in the study and be available for two study visits that will occur at baseline and approximately 6-month after the baseline visit.
- Report at least 1 alcohol binge drinking episode in the past month (binge drinking is defined as 4 or more drinks in a 2 hour period for women, 5 or more drinks in a 2 hour period for men (NIAAA, 2004) OR report the use of marijuana on at least 1 occasion in the past month.
- Have access to an email account or phone number to communicate with study personnel.
- Identify as a member of a minority group, disadvantaged group, or marginalized based on race, ethnicity, heritage, immigration status, gender, sexual orientation, religion, and disability status.
Exclusion
- In the past month, consumed an average of 7 or more drinks per week for females or 14 or more drinks per week for males.
- Marijuana use on 4 or more days per week in the past month.
- A pattern of impaired functioning due to alcohol or marijuana use during the past month;
- In the past year, family members, close friends, or medical providers have expressed concerns about their alcohol or marijuana use and have advised them to quit.
- A history of a Substance Use Disorders (Alcohol; Amphetamines; Cannabis; Cocaine; Hallucinogens; Opioids; Phencyclidine; and Sedatives, Hypnotics and Anxiolytics).
- A history of a chronic and/or severe psychiatric disorder that would interfere with participation (i.e., Schizophrenia, Delusional Disorder, Schizoaffective Disorder, Bipolar Disorder, or a Mood Disorder with Psychotic Features).
- Unavailable for a 2.5 hour baseline visit and a follow-up visit 6 months post baseline.
- Unable to provide contact information to allow for study related communication.
- Pregnant or nursing.
- Identified as a UH student that the PI (Dr. Marcel de Dios) has had or will likely have direct access to or influence over through academic activities such as coursework, advising, or research mentoring.
- Identified by the study PI as unsuitable for participating in the study due to significant circumstances that would interfere with participation including threatening behavior or an inability/unwillingness to respond to basic study related questions and instructions.
Key Trial Info
Start Date :
January 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2020
Estimated Enrollment :
44 Patients enrolled
Trial Details
Trial ID
NCT03801096
Start Date
January 1 2019
End Date
October 1 2020
Last Update
January 11 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.